SCHEMBL14104079

SCHEMBL14104079

N#Cc1ccc(Oc2nc(-c3cccc(F)c3)nc3ccsc23)c(F)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 6/20 0.36
▸ CYP3A4 P08684 5/20 0.36
▸ TSHR P16473 4/20 0.36
▸ CYP2D6 P10635 4/20 0.36
▸ ABCG2 Q9UNQ0 3/20 0.36
▸ MEN1 O00255 5/20 0.35
▸ KMT2A Q03164 5/20 0.35
▸ CLK4 Q9HAZ1 4/20 0.35
▸ CYP2C19 P33261 4/20 0.35
▸ LMNA P02545 4/20 0.35
▸ ALDH1A1 P00352 3/20 0.35
▸ HSD17B10 Q99714 3/20 0.35
▸ CYP2C9 P11712 3/20 0.35
▸ MAPK1 P28482 2/20 0.35
▸ SCN9A Q15858 1/20 0.35
▸ PRKCI P41743 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ TP53 P04637 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ GABRG2 P18507 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11990372 0.91 AR (0.39) CYP1A2CYP3A4TSHRCYP2D6ABCG2
SCHEMBL4743431 0.91 MAPK1 (0.40) CYP1A2CYP3A4TSHRCYP2D6ABCG2
SCHEMBL4738829 0.90 NR1I3 (0.40) CYP1A2CYP3A4TSHRCYP2D6ABCG2
SCHEMBL4740912 0.90 ABCG2 (0.35) CYP1A2CYP3A4TSHRCYP2D6ABCG2
SCHEMBL14103801 0.90 PIK3CA (0.43) CYP1A2CYP3A4TSHRCYP2D6ABCG2
SCHEMBL14103886 0.89 ABCG2 (0.44) CYP1A2CYP3A4TSHRCYP2D6ABCG2
SCHEMBL4740295 0.89 PTGS1 (0.40) ABCG2MEN1KMT2ACYP2C19ALDH1A1
SCHEMBL4573992 0.86 MAPK1 (0.44) ABCG2CYP2C19CYP2C9MAPK1SCN9A
SCHEMBL14103792 0.85 L3MBTL1 (0.36) CYP2C19CYP2C9SCN9APRKCIGABRG2
SCHEMBL14104167 0.85 KDM4E (0.35) MEN1KMT2ACYP2C19LMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008092861-A1 BICYCLIC DERIVATIVES AS EP4 AGONISTS JANSSEN PHARMACEUTICA N.V. (BE) 2008-08-07 — — WO disclosed
Send feedback